Method for assessing predisposition to depression
The present invention relates to diagnostic methods for assessing predisposition of a subject to a mental disorder phenotype having an association with an at-risk allele of a brain-functional gene having a plurality of alleles, the association being conditioned by a pathogenic environmental risk factor status condition. Additionally, the invention relates to methods for discovering a conditional association between a mental disorder phenotype and an at-risk allele of a brain-functional gene having a plurality of alleles, the association being conditioned by a pathogenic environmental risk factor status condition.
1. A method for detecting one or more copies of a short promoter allele of a 5-HTT gene and diagnosing a predisposition to depression in a human subject who has experienced a stressful life event, the method comprising the steps of:
a) performing a genotyping assay on a nucleic acid sample of said human subject to detect the presence of one or more copies of the short promoter allele of the 5-HTT gene, and
b) determining that the human subject is predisposed to depression if the human subject has one or more copies of the short promoter allele of the 5-HTT gene.
2. A method for detecting one or more copies of a short promoter allele of a 5-HTT ene and performing a therapy in a human subject who has experienced a stressful life event, the method comprising the steps of:
a) performing a genotyping assay on a nucleic acid sample of said human subject to detect the presence of one or more copies of a short promoter allele of the 5-HTT gene,
b) determining that the human subject is predisposed to depression if the human subject has one or more copies of the short promoter allele of the 5-HTT gene, and
c) treating the human subject determined in step b) to be predisposed to depression in a manner consistent with predisposition to depression, the manner selected from the group consisting of counseling the subject to pursue or avoid a particular type of employment and prescribing a therapy.
3. The method of claim 1 , wherein the genotyping assay comprises amplifying a portion of the 5-HTT gene using an amplification primer pair that distinguishes the short promoter allele from other alleles of the 5-HTT gene; and determining whether the amplified portion is a fragment of the short promoter allele.
4. The method of claim 3 , wherein the amplification primer pair comprises a first primer having the sequence of SEQ ID NO: 3 and a second primer having the sequence of SEQ ID NO: 4.
5. The method of claim 2 , wherein the therapy is selected from the group consisting of psychological therapy and pharmaceutical therapy.
6. The method of claim 5 , wherein the pharmaceutical therapy comprises treatment with an anti-depressive agent.